Autopsy report · NCT01530399

Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery

“Safety”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 8 months before it stopped.
• 44 participants enrolled.
• Results were posted on the registry 3 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

The Medicines Company

Sponsor type

Industry

Conditions

Bleeding

Interventions

MDCO 1; MDCO 2; MDCO 3; MDCO 4; Tranexamic Acid; Saline

Participants

44

Sites

5

Countries

Germany, Switzerland

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.